Position in TGTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$17,119,195
+$1,845,208 QoQ
Shares Held
515,328
+0.6% QoQ
Ownership
0.337%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 99.89055514157972.ToString("F0")%
Shared 0.ToString("F0")%
None 0.10944485842026826.ToString("F0")%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Derivatives in TGTX
reported options exposure · as of Mar 31, 2024CallValue
$988,650
CallShares
65,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF MONTREAL /CAN/ holds $580,215,891 across 80 Biotechnology names. TGTX ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
390,476 | $174,363,150 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,055,597 | $68,223,231 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,524 | $66,079,260 | |
| 4 | ARGX |
Argenx SE
|
85,333 | $62,314,421 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
239,265 | $45,233,045 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
86,183 | $17,206,434 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
This page
|
515,328 | $17,119,195 | |
| 8 | INCY |
Incyte Corp
|
171,790 | $16,168,871 |
All Filings in TGTX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,119,195 | 515,328 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $15,273,987 | 512,378 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $18,518,215 | 512,615 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $18,903,530 | 525,244 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $20,680,048 | 524,475 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $602,481 | 20,016 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $436,433 | 18,659 | Shares | Defined | 2024-11-13 | |
| 2024-03-31 | $740,344 | 48,675 | Shares | Defined | 2024-05-13 | |
| 2024-03-31 | $988,650 | 65,000 | Call | Defined | 2024-05-13 | |
| 2023-06-30 | $3,177,854 | 127,933 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $1,748,083 | 116,229 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $2,860,860 | 241,831 | Shares | Defined | 2023-02-01 | |
| 2022-12-31 | $983,073 | 83,100 | Put | Defined | 2023-02-01 | |
| 2022-09-30 | $490,768 | 82,900 | Put | Defined | 2022-11-10 | |
| 2022-09-30 | $514,163 | 86,852 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $352,325 | 82,900 | Put | Defined | 2022-08-11 | |
| 2022-06-30 | $354,666 | 83,451 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $788,379 | 82,900 | Put | Defined | 2022-05-12 | |
| 2022-03-31 | $791,783 | 83,258 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,477,763 | 77,777 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,615,008 | 78,576 | Shares | Defined | 2021-11-12 | |
| 2021-09-30 | $2,575,872 | 77,400 | Put | Defined | 2021-11-12 | |
| 2021-06-30 | $3,064,719 | 79,008 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $323,180 | 6,705 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,027,914 | 19,760 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $140,623 | 5,255 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $160,144 | 8,221 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||